Recent Advances in Asymmetric Hydrogenation Catalysis Utilizing Spiro and Other Rigid C-Stereogenic Phosphine Ligands

Design and Synthesis of Chiral Spiro Monophosphinites with a 3-Oxo-1,1'-spirobiindane Scaffold and Their Application in Rhodium-Catalyzed Asymmetric Hydrogenation of Dehydroamino Acid Esters

A new class of chiral spiro monophosphinites, based on a unique non-C2-symmetric 3-oxo-1,1'-spirobiindane scaffold featuring a large dihedral angle, has been effectively designed and synthesized. From readily accessible resources, these chiral spiro monophosphinites were synthesized via eight steps in 16-32% yields. Their excellent performance in the rhodium-catalyzed asymmetric hydrogenation of β-dehydroamino acid esters underscores the critical impact of the large dihedral angle in enhancing the activity and enantioselectivity.

An Aziridine and a 2-Pyrrolidone with Pyridyl Sidearms as Ligands for Cationic Rh(I)-Catalyzed Hydrosilylation and Hydrogenation of C=C and C≡C Bonds

Phosphine- or carbene-based soft ligands are customarily used in Rh and other late transition metal catalyzed alkene and alkyne hydrosilylation and hydrogenation. We report here an aziridine and a 2-pyrrolidone with pyridyl sidearms, whose cationic Rh(I) complexes prove as excellent catalysts for hydrosilylating terminal olefins by Et3SiH giving anti-Markovnikov products selectively. To the best of our knowledge, the [(2-pyrrolidone)-Rh]+ seems to be the most active Rh catalyst recording a highest TOF of 24000 h-1. It works remarkably (TOF: 714 h-1) even at 10 ppm concentration! Terminal alkynes are hydrosilylated too to give β-(Z)-vinylsilanes selectively. Both catalysts also hydrogenate alkenes and doubly-hydrogenate alkynes, both terminal and internal, under ambient and benchtop conditions. But in hydrogenation, the [(aziridine)-Rh]+ catalyst works better. Both ligands and the Rh catalysts are air-stable.

Copper-Catalyzed Asymmetric Hydrogenation of Unsymmetrical ortho-Br Substituted Benzophenones

The asymmetric hydrogenation of benzophenones, catalyzed by low-activity earth-abundant metal copper, has hitherto remained a challenge due to the substrates equipped with two indistinguishably similar aryl groups. In this study, we demonstrated that the prochiral carbon of the ortho-bromine substrate exhibits the highest electrophilicity and high reactivity among the ortho-halogen substituted benzophenones, as determined by the Fukui function (f+) analysis and hydrogenation reaction. Considering that the enantiodirecting functional bromine group can be easily derivatized and removed in the products, we successfully achieved a green copper-catalyzed asymmetric hydrogenation of ortho-bromine substituted benzophenones. This method yielded a series of chiral benzhydrols with excellent results. The utility of this protocol has been validated through a gram-scale reaction and subsequent product transformations. Independent gradient model based on Hirshfeld partition (IGMH) and energy decomposition analysis (EDA) indicate that the CH⋅⋅⋅HC multiple attractive dispersion interactions (MADI) effect between the catalyst and substrate enhances the catalyst's activity.

Recent advances in the enantioselective synthesis of chiral sulfones via asymmetric hydrogenation

Chiral sulfones are key structural motifs that extensively exist in natural products, drugs, and biologically active compounds. During the past few decades, rapid development has been made with respect to the highly enantioselective synthesis of chiral sulfones, in which the catalytic asymmetric hydrogenation of unsaturated sulfones provides an efficient and powerful methodology to construct chiral sulfones and their derivatives. This review highlights the progress achieved in transition metal (ruthenium, rhodium, iridium, and nickel) catalyzed direct asymmetric hydrogenation of a variety of unsaturated sulfones from the aspects of the substrate scope, catalytic mechanisms, and applications in the synthesis of biologically active molecules.

Application of mixed phosphorus/sulfur ligands based on terpenoids in Pd-catalyzed asymmetric allylic substitution and Rh-catalyzed hydrogenation

A small library of easily prepared diamidophosphite-sulfides based on 1,3-thioether alcohols, primarily of terpenoid nature, was developed. Upon complexation with Pd(II) ions, these hemilabile ligands showed the ability to form both P,S-chelates and complexes with two ligands P-monodentately bonded to the metal. The structures of the ligands and their complexes were determined by 2D NMR spectroscopy and X-ray diffraction. The use of these stereoselectors provided up to 95% ee in the classic Pd-catalyzed asymmetric allylic substitution reactions of (E)-1,3-diphenylallyl acetate with C- and N-nucleophiles and up to 80% ee in the Pd-mediated allylic alkylation of cinnamyl acetate with β-ketoesters. In addition, ee values of up to 90% with quantitative conversion were achieved in the Rh-catalyzed asymmetric hydrogenation of methyl esters of unsaturated acids. The effects of the structural parameters, reaction conditions and ligand-to-metal ratio on the catalytic results are discussed.

Asymmetric Additions Empowered by OrganoCatalysts, Metal Catalysts, and Deep Natural Eutectic Solvents (NADES)

This article is a history of an industrial-academic partnership that started almost two decades ago and details the evolution of a relationship between a small academic research group and a spin-out company located in Portugal. Their activities have ranged from the development of new metal-based catalytic systems for asymmetric epoxidations, allylic alkylations, and arylations to the development of novel cinchona-based organocatalysts for asymmetric hydrosilylations and Michael additions. Current common interests are centered on the development of novel chiral Natural Deep Eutectic Solvent systems, which they are investigating in different types of reaction systems.

Copper-Catalyzed Chemoselective Asymmetric Hydrogenation of C=O Bonds of Exocyclic α,β-Unsaturated Pentanones

A highly chemoselective earth-abundant transition metal copper catalyzed asymmetric hydrogenation of C=O bonds of exocyclic α,β-unsaturated pentanones was realized using H2 . The desired products were obtained with up to 99 % yield and 96 % ee (enantiomeric excess) (99 % ee, after recrystallization). The corresponding chiral exocyclic allylic pentanol products can be converted into several bioactive molecules. The hydrogenation mechanism was investigated via deuterium-labelling experiments and control experiments, which indicate that the keto-enol isomerization rate of the substrate is faster than that of the hydrogenation and also show that the Cu-H complex can only catalyze chemoselectively the asymmetric reduction of the carbonyl group. Computational results indicate that the multiple attractive dispersion interactions (MADI effect) between the catalyst with bulky substituents and substrate play important roles which stabilize the transition states and reduce the generation of by-products.

Nickel-Catalyzed Asymmetric Hydrogenation of α-Substituted Vinylphosphonates and Diarylvinylphosphine Oxides

Chiral α-substituted ethylphosphonate and ethylphosphine oxide compounds are widely used in drugs, pesticides, and ligands. However, their catalytic asymmetric synthesis is still rare. Of the only asymmetric hydrogenation methods available at present, all cases use rare metal catalysts. Herein, we report an efficient earth-abundant transition-metal nickel catalyzed asymmetric hydrogenation affording the corresponding chiral ethylphosphine products with up to 99 % yield, 96 % ee (enantiomeric excess) (99 % ee, after recrystallization) and 1000 S/C (substrate/catalyst); this is also the first study on the asymmetric hydrogenation of terminal olefins using a nickel catalyst under a hydrogen atmosphere. The catalytic mechanism was investigated via deuterium-labelling experiments and calculations which indicate that the two added hydrogen atoms of the products come from hydrogen gas. Additionally, it is believed that the reaction involves a Ni^II rather than Ni⁰ cyclic process based on the weak attractive interactions between the Ni catalyst and terminal olefin substrate.

Asymmetric organocatalysis in drug discovery and development for active pharmaceutical ingredients

INTRODUCTION

Over the last 20 years, it has become clear that organocatalysis is the third pillar of catalysis. The low reactivity in the early days of organocatalysis has been overcome with the invention of more efficient catalysts, and by harnessing enabling technologies like continuous-flow chemistry and photo-redox catalysis.

AREAS COVERED

The main focus of this review is on the development over the last 10-15 years of key APIs using asymmetric organocatalysis. Due to significant engineering advances, and also due to the need for continuous manufacturing, flow and photo-redox approaches are becoming more widespread.

EXPERT OPINION

Over the last 20 years, organocatalysis has been used on various occasions for accessing chiral drugs. The great advantage of using these catalysts is that the final active pharmaceutical ingredient (API) is metal-free. Also due to their inherent stability in air and water, they are very amenable to recovery via attachment to appropriate solid supports and also application in continuous flow systems. In recent years, more efficient organocatalysts have been developed, which includes the photoredox types, with much potential for chiral API synthesis.

Access to Phosphine-Containing Quinazolinones Enabled by Photo-Induced Radical Phosphorylation/Cyclization of Unactivated Alkenes

A mild and facile photo-induced cascade radical addition/cyclization of unactivated alkenes has been reported, through which a variety of biologically valuable phosphine-containing quinazolinones could be obtained in moderate to good yields. The protocol was characterized by mild conditions, broad substrate scope, and high atomic economy.